Results 51 to 60 of about 5,950 (190)
Australian Veterinary Journal, EarlyView.Clinical scenario Canine osteoarthritis (OA) is a degenerative joint disease and is one of the most common chronic conditions in dogs and other species. The management of OA remains a longstanding focus in veterinary medicine. Traditionally, nonsteroidal anti‐inflammatory drugs (NSAIDs) have been the first‐line treatment option for canine OA. Recently,
X Yang, P Macarthur
wiley +1 more source
Regulating risks in pharmaceutical law : the need of an optimal interplay between products safety and products liability [PDF]
, 2011 Published online: 7 June 2011The aim of this paper is to call for the need of a theoretical model of pharmaceutical products safety in which the two systems of regulation and liability operate complementarily. The question is why two legal tools that are
RIZZI, Marco
core
Self-controlled case series with multiple event types [PDF]
, 2017 Self-controlled case series methods for events that may be classified as one of several types are described. When the event is non-recurrent, the different types correspond to competing risks.
Douglas, Ian J. +4 more
core +1 more source
Nelarabine Associated Myotoxicity and Rhabdomyolysis
Case Reports in Hematology, 2015 Nelarabine (ara-G; Arranon; compound 506U78) is an antineoplastic purine analog used for the treatment of refractory or relapsed T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL).
Mahnur Haider +2 more
doaj +1 more source
Drug therapeutic failures as a cause of admission to an intensive care unit at a university hospital
Journal of Research in Pharmacy Practice, 2019 Objective: Drug therapeutic failures (TFs) are included in pharmacovigilance reporting, as some authors consider them a type of adverse drug reaction.
Jair Antonio Ruiz-Garzon +2 more
doaj +1 more source
Clinical Pharmacology &Therapeutics, Volume 119, Issue 5, Page 1179-1194, May 2026.Maternal health remains a critical global concern, particularly in underserved populations and in low‐ and middle‐income countries where access to safe and effective therapeutics is limited. Despite the use of medications by most women during pregnancy, the exclusion of pregnant and lactating women from clinical trials has resulted in significant data ...
Rachel K. Scott +7 more
wiley +1 more source
The US Food and Drug Administration’s expedited approval programs: Evidentiary standards, regulatory trade-offs, and potential improvements [PDF]
, 2018 The United States Food and Drug Administration (FDA) has several regulatory programs and pathways to expedite the development and approval of therapeutic agents aimed at treating serious or life-debilitating conditions. A common feature of these programs
Naci, Huseyin +2 more
core +1 more source
Clinical Pharmacology &Therapeutics, Volume 119, Issue 5, Page 1350-1361, May 2026.Regional differences in approved drug dosages and administration are shaped by complex factors, including clinical data, prior regulatory decisions, and region‐specific considerations. This study investigated how such factors are associated with variations in approved doses across the United States Food and Drug Administration (FDA), European Medicines
Sachiko Mita, Shunsuke Ono
wiley +1 more source
Post-Market Surveillance Study of a Skull Flap Fixation Device: Cranfixer
Iranian Journal of Neurosurgery, 2019 Background and Aim: Cranfixer was approved in 2017 by the Food and Drug Administration of Iran as a skull flap fixation and also a burr hole cover.
Seyed Roholah Ghodsi +3 more
doaj